Cited by 173Bone health and osteoporosis researchHormonal and reproductive studiesMenopause: Health Impacts and Treatments

Bioavailable Estradiol May Be an Important Determinant of Osteoporosis in Men: The MINOS Study

Szulc, P.·2001·Journal of Clinical Endocrinology & Metabolism

Integrity signals

Registry

Crossref · 10.1210/jc.86.1.192

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Aromatase inhibitors effectively delay epiphysial maturation in boys.

    “Aromatase inhibitors effectively delay epiphysial maturation in boys and improve testosterone levels in adult men”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [60]

  • Plasma estradiol levels were mostly lower in the letrozole-treated group.

    “In spite of this fact, plasma estradiol levels were mostly lower in the letrozole-treated group.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [60]

  • Both groups showed similar growth velocity but bone age progressed significantly slower in the letrozole group resulting in a gain of 5.9 cm in predicted adult height.

    “Both groups showed similar growth velocity but bone age progressed significantly slower in the letrozole group resulting in a gain of 5.9 cm in predicted adult height.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [60]

  • Letrozole treatment was associated with higher plasma levels of gonadotropins and testosterone in boys who entered puberty during the study.

    “Letrozole treatment was associated with higher plasma levels of gonadotropins and testosterone in boys who entered puberty during the study.”

    From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [60]

Cites

The publisher hasn’t deposited this paper’s reference list.

Cited by

Sorted by citations

Authors
Szulc, P.
Corresponding author
Szulc, P.
Venue
Journal of Clinical Endocrinology & Metabolism
Published
2001-01-01
Volume
86
Issue
1
Pages
192-199
ISSN
0021-972X (ISSN-L)
OpenAlex
W4253938871
Cited by
169
References
0
Citations by year
2024: 1 · 2023: 4 · 2022: 4 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 4 · 2013: 7 · 2012: 7
FWCI
13.68
Type
journal article
Language
en
Open access
closed
Locations
The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
bioavailable estradiol, male osteoporosis, bone mineral density, sex steroids, men's health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review